CONMED CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
CONMED CORPORATION (CNMD) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of 1.60% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2025-02-18
- CONMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for the quarter ending 2018-03-31 was 2.60%.
- CONMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was 1.60%.
- CONMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was 0.00%, a 100.00% decline from fiscal 2022.
- CONMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was 1.50%.
- CONMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2021 was -9.40%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | 1.60% 10-K · filed 2025-02-18 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-02-18 | |||
| 2022-12-31 | 1.50% 10-K · filed 2025-02-18 | |||
| 2021-12-31 | -9.40% 10-K · filed 2024-02-28 | |||
| 2020-12-31 | -267.70% 10-K · filed 2023-02-21 | |||
| 2019-12-31 | -15.40% 10-K · filed 2022-02-22 | |||
| 2018-12-31 | -1.60% 10-K · filed 2021-02-22 | 1.60% 10-K · filed 2019-02-25 | ||
| 2018-06-30 | 3.00% 10-Q · filed 2018-08-02 | |||
| 2018-03-31 | 2.60% 10-Q · filed 2018-04-26 | |||
| 2017-12-31 | -2.10% 10-K · filed 2020-02-24 | 2.10% 10-K · filed 2018-02-26 | ||
| 2017-06-30 | 12.70% 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | 0.00% 10-K · filed 2019-02-25 | |||
| 2015-12-31 | 0.00% 10-K · filed 2018-02-26 | |||
| 2014-12-31 | 0.20% 10-K · filed 2017-02-27 | -0.20% 10-K · filed 2015-02-23 | ||
| 2013-12-31 | 0.50% 10-K · filed 2016-02-23 | -0.50% 10-K · filed 2014-02-24 | ||
| 2012-12-31 | -0.20% 10-K · filed 2015-02-23 | -0.16% 10-K · filed 2013-02-25 | ||
| 2011-12-31 | -1.60% 10-K · filed 2014-02-24 | -1.61% 10-K · filed 2012-02-28 | ||
| 2010-12-31 | 0.01% 10-K · filed 2013-02-25 | |||
| 2009-12-31 | 1.59% 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |